Drug Pipeline

TYRA-300 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06995677 Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade… Low-grade NMIBC Recruiting
NCT07265947 Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract… Low Grade Upper Tract Urothelial Carcinoma Recruiting
NCT06842355 A Study of TYRA-300 in Children With Achondroplasia: BEACH301 Achondroplasia Recruiting
Phase 1/2
NCT05544552 Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma… Locally Advanced Urothelial Carcinoma Active, Not Recruiting
Sponsors Running TYRA-300 Trials
Tyra Biosciences, Inc (4)
Disease Areas
Bladder Cancer (2)
Get alerts when TYRA-300 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free